Glycomics/Glycobiology Market - Global Forecast 2025-2030

The glycomics and glycobiology market is at a pivotal inflection point, rapidly evolving as a critical segment within life sciences. Driven by advances in analytical methodology, strategic collaboration, and rising therapeutic demand, this market promises substantial business development opportunities for organizations seeking to leverage molecular innovation and translational research platforms.

Market Snapshot: Glycomics and Glycobiology Market Size and Growth

The glycomics/glycobiology market grew from USD 1.54 billion in 2024 to USD 1.76 billion in 2025, and is set to continue expanding at a CAGR of 16.46%, reaching USD 3.84 billion by 2030. Market expansion is supported by increased investment in high-throughput platforms, growing clinical relevance of complex sugar analysis, and integration of glycan profiling into biomarker discovery and drug development.

Scope & Segmentation of Global Glycomics and Glycobiology

Product Types: Enzymes (including glycosidases, neuramidases, glycosyltransferases, sialyltransferases, protein sulfotransferases, sulfatases), instruments (arrays, chromatography instruments, electrophoresis instruments, HPLC columns, mass spectrometry instruments), kits (glycan labeling, purification, glycoprotein labeling), reagents, and chemicals.
Application Domains: Diagnostics (cancer detection, genetic disorders, infectious diseases) and therapeutics (drug delivery systems, drug development, drug discovery).
End-User Profiles: Academic research institutes, contract research organizations, pharmaceutical companies, and biotechnology firms.
Regional Markets: Americas (including the US states such as California, Texas, and New York; and countries such as Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
Technology Focus: High-resolution mass spectrometry, microarray-based glycoprofiling, liquid chromatography-tandem MS, MALDI-TOF, glycan labeling techniques, machine learning for data integration, and bioinformatics pipeline optimization.
Company Coverage: Major industry participants include Agilent Technologies, AMSBIO, Asparia Glycomics, Bio-Techne Corporation, Bruker Corporation, Chemily Glycoscience, Creative Diagnostics, FUJIFILM Wako Pure Chemical Corporation, Genos Glyco, Glycan Therapeutics, GlycoDiag, glyXera GmbH, ICE S.p.a., Lectenz Bio, Ludger Ltd, Megazyme Ltd. by Neogen Corporation, Merck KGaA, New England Biolabs, QIAGEN, RayBiotech, Revvity, SCIEX by Danaher, Shimadzu Corporation, Sumitomo Bakelite, Takara Bio, Thermo Fisher Scientific, Tokyo Chemical Industry, Vector Laboratories, Waters Corporation, Z Biotech, and Zacharon Pharmaceuticals.

Key Takeaways for Senior Decision-Makers

Heightened demand for advanced analytical platforms is transforming glycomics from a niche scientific pursuit into an operationally relevant function for diagnostics, therapeutics, and R&D workflows.
Collaborations between instruments manufacturers, academic research groups, and pharmaceutical firms are fostering modular solutions spanning sample preparation, high-resolution analysis, and interpretive bioinformatics.
The evolution from single-enzyme assays to end-to-end, multi-omics platforms is streamlining workflows, reducing cycle times, and unlocking broader translational applications.
Regional initiatives in North America, Europe, and Asia-Pacific are driving tailored infrastructure development, targeted investment, and regulatory harmonization, shaping uptake and innovation pace.
Emergent use of machine learning to integrate large glycan datasets is guiding experimental design and resource allocation across departments.
Product development is increasingly influenced by ongoing talent development and training initiatives in glycan analytics, ensuring a competent workforce to support scientific and commercial priorities.

Tariff Impact: Effects of U.S. Tariff Adjustments on the Glycomics Supply Chain

Recent U.S. tariff adjustments have introduced greater complexity into global glycomics supply chains. Import duties on key reagents, chromatography columns, and mass spectrometry accessories are raising procurement costs and lengthening lead times. In response, end-users and manufacturers are adopting locally sourced alternatives, reconfiguring supplier agreements, and emphasizing operational efficiency to mitigate risk and maintain research continuity.

Methodology & Data Sources

This market analysis is based on a blended methodology encompassing primary interviews with subject-matter experts, in-depth secondary research, multi-phase data validation, and proprietary analytical modeling to forecast trends and quantify segment performance.

Why This Report Matters

Delivers actionable insights for organizations aiming to leverage technological innovation, supply chain adaptation, and partnership models to maximize market impact.
Facilitates data-driven strategic planning, risk mitigation, and investment prioritization aligned with both scientific trends and regulatory environments.
Enables senior stakeholders to benchmark competitive positioning, identify novel opportunities, and inform multi-year growth plans based on robust, expert-validated intelligence.

Conclusion

The glycomics and glycobiology market stands poised for further expansion, shaped by multi-disciplinary innovation, evolving regional priorities, and growing clinical adoption. Strategic alignment with key trends can unlock sustained value and drive advancement across life sciences sectors.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Rapid expansion of high-throughput glycan sequencing platforms enabling comprehensive biomarker discovery
5.2. Integration of AI-driven glycome data analytics for personalized disease diagnostics and therapy optimization
5.3. Advances in synthetic glycan library development for targeted vaccine and oncology therapeutic research
5.4. Growing adoption of mass spectrometry imaging for site-specific glycoprotein profiling in clinical applications
5.5. Collaborative consortia driving standardized glycan nomenclature and data sharing for global research harmonization
5.6. Emergence of glycoengineering techniques in biopharmaceuticals to improve monoclonal antibody efficacy and safety
5.7. Increasing investment in microarray-based glycan screening tools for rapid infectious disease outbreak response
5.8. Development of label-free real-time glycan interaction assays for accelerated drug candidate screening

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Glycomics/Glycobiology Market, by Product Type

8.1. Introduction
8.2. Enzymes
8.2.1. Glycosidases & Neuramidases
8.2.2. Glycosyltransferases & Sialytransferases
8.2.3. Protein Sulfotransferases & Sulfatases
8.3. Instruments
8.3.1. Arrays
8.3.2. Chromatography Instruments
8.3.3. Electrophoresis Instruments
8.3.4. HPLC Columns
8.3.5. Mass Spectrometry Instruments
8.4. Kits
8.4.1. Glycan Labeling Kits
8.4.2. Glycan Purification Kits
8.4.3. Glycoprotein Labeling Kits
8.5. Reagents & Chemicals

9. Glycomics/Glycobiology Market, by Applications

9.1. Introduction
9.2. Diagnostics
9.2.1. Cancer Detection
9.2.2. Genetic Disorders
9.2.3. Infectious Diseases
9.3. Therapeutics
9.3.1. Drug Delivery Systems
9.3.2. Drug Development
9.3.3. Drug Discovery

10. Glycomics/Glycobiology Market, by End-User

10.1. Introduction
10.2. Academic Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology Companies

11. Americas Glycomics/Glycobiology Market

11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina

12. Europe, Middle East & Africa Glycomics/Glycobiology Market

12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland

13. Asia-Pacific Glycomics/Glycobiology Market

13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan

14. Competitive Landscape

14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Agilent Technologies, Inc.
14.3.2. AMSBIO
14.3.3. Asparia Glycomics
14.3.4. Bio-Techne Corporation
14.3.5. Bruker Corporation
14.3.6. Chemily Glycoscience
14.3.7. Creative Diagnostics
14.3.8. FUJIFILM Wako Pure Chemical Corporation
14.3.9. Genos Glyco
14.3.10. Glycan Therapeutics
14.3.11. GlycoDiag
14.3.12. glyXera GmbH
14.3.13. ICE S.p.a.
14.3.14. Lectenz Bio, Inc.
14.3.15. Ludger Ltd
14.3.16. Megazyme Ltd. by Neogen Corporation
14.3.17. Merck KGaA
14.3.18. New England Biolabs, Inc.
14.3.19. QIAGEN N.V.
14.3.20. RayBiotech, Inc.
14.3.21. Revvity, Inc.
14.3.22. SCIEX by Danaher Corporation
14.3.23. Shimadzu Corporation
14.3.24. Sumitomo Bakelite Co., Ltd.
14.3.25. Takara Bio Inc.
14.3.26. Thermo Fisher Scientific Inc.
14.3.27. Tokyo Chemical Industry Co., Ltd.
14.3.28. Vector Laboratories, Inc.
14.3.29. Waters Corporation
14.3.30. Z Biotech, LLC
14.3.31. Zacharon Pharmaceuticals, Inc.

15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix

List of Figures

FIGURE 1. GLYCOMICS/GLYCOBIOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLYCOMICS/GLYCOBIOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. GLYCOMICS/GLYCOBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. GLYCOMICS/GLYCOBIOLOGY MARKET: RESEARCHAI
FIGURE 22. GLYCOMICS/GLYCOBIOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 23. GLYCOMICS/GLYCOBIOLOGY MARKET: RESEARCHCONTACTS
FIGURE 24. GLYCOMICS/GLYCOBIOLOGY MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. GLYCOMICS/GLYCOBIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSIDASES & NEURAMIDASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSIDASES & NEURAMIDASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSYLTRANSFERASES & SIALYTRANSFERASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSYLTRANSFERASES & SIALYTRANSFERASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PROTEIN SULFOTRANSFERASES & SULFATASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PROTEIN SULFOTRANSFERASES & SULFATASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ELECTROPHORESIS INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ELECTROPHORESIS INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY HPLC COLUMNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY HPLC COLUMNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN LABELING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN LABELING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN PURIFICATION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN PURIFICATION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOPROTEIN LABELING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOPROTEIN LABELING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REAGENTS & CHEMICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REAGENTS & CHEMICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CANCER DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CANCER DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 116. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 117. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 118. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 119. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 120. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 121. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 122. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 123. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 124. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 125. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 126. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 127. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 132. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 133. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 142. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 214. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 215. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 216. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 217. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 218. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 219. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 220. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 221. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 222. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 223. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 224. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 225. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 230. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 231. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 232. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 233. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 234. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 235. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 236. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 237. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 240. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 241. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 242. FRANCE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 262. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 263. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 264. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 265. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 266. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 267. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 268. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 269. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 270. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 271. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 272. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 273. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. ITALY GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 278. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 279. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 280. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 281. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 282. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 283. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 284. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 285. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 286. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 287. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 288. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 289. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 290. SPAIN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 322. SAUDI ARABIA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLIO

Samples

LOADING...

Companies Mentioned

The companies profiled in this Glycomics/Glycobiology market report include:

Agilent Technologies, Inc.
AMSBIO
Asparia Glycomics
Bio-Techne Corporation
Bruker Corporation
Chemily Glycoscience
Creative Diagnostics
FUJIFILM Wako Pure Chemical Corporation
Genos Glyco
Glycan Therapeutics
GlycoDiag
glyXera GmbH
ICE S.p.a.
Lectenz Bio, Inc.
Ludger Ltd
Megazyme Ltd. by Neogen Corporation
Merck KGaA
New England Biolabs, Inc.
QIAGEN N.V.
RayBiotech, Inc.
Revvity, Inc.
SCIEX by Danaher Corporation
Shimadzu Corporation
Sumitomo Bakelite Co., Ltd.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Tokyo Chemical Industry Co., Ltd.
Vector Laboratories, Inc.
Waters Corporation
Z Biotech, LLC
Zacharon Pharmaceuticals, Inc.

Table Information

Report Attribute	Details
No. of Pages	184
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 1.76 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.84 Billion
Compound Annual Growth Rate	16.4%
Regions Covered	Global
No. of Companies Mentioned	32

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3149EUR$3,545USD£2,732GBP €3499EUR$3,939USD£3,036GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3396EUR$3,824USD£2,947GBP €3774EUR$4,249USD£3,275GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4603EUR$5,183USD£3,995GBP €5115EUR$5,759USD£4,439GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5571EUR$6,272USD£4,834GBP €6190EUR$6,969USD£5,371GBP

Market Snapshot: Glycomics and Glycobiology Market Size and Growth

Scope & Segmentation of Global Glycomics and Glycobiology

Key Takeaways for Senior Decision-Makers

Tariff Impact: Effects of U.S. Tariff Adjustments on the Glycomics Supply Chain

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Related Topics

Related Reports

Glycomics Or Glycobiology Market Report 2025

Glycomics / Glycobiology - Global Strategic Business Report

Glycobiology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Glycobiology Market Report and Forecast 2025-2034

Glycomics Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033